{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:03:51Z","timestamp":1789877031194,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1007\/bf03343730","type":"journal-article","created":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T08:56:45Z","timestamp":1394528205000},"page":"321-324","source":"Crossref","is-referenced-by-count":25,"title":["Long-term treatment with interferon-\u03b2 therapy for multiple sclerosis and occurrence of Graves\u2019 disease"],"prefix":"10.1007","volume":"23","author":[{"given":"M.","family":"Rotondi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Mazziotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Manganella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Del Buono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Montella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"di Cristofaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Di Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Carella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,11]]},"reference":[{"key":"BF03343730_CR1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1212\/WNL.43.4.655","volume":"43","author":"The IFN \u03b2 Multiple Sclerosis Study Group.","year":"1993","unstructured":"The IFN \u03b2 Multiple Sclerosis Study Group. Interferon beta 1-b is effective in relapsing-remitting multiple sclerosis: clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993, 43: 655\u2013661.","journal-title":"Neurology"},{"key":"BF03343730_CR2","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1212\/WNL.45.7.1277","volume":"45","author":"I \u03b2 Multiple Sclerosis Study Groupthe University of British Columbia MS\/MRI Analysis Group M S S G U o B C M A Group The","year":"1995","unstructured":"The IFN \u03b2 Multiple Sclerosis Study Group and the University of British Columbia MS\/MRI Analysis Group. Interferon beta 1-b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995, 45: 1277\u20131285.","journal-title":"Neurology"},{"key":"BF03343730_CR3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0140-6736(85)90203-X","volume":"8946","author":"P Burman","year":"1985","unstructured":"Burman P., Karlsson F.A., Oberg K., Alm G. Autoimmune thyroid disease in interferon treated patients. Lancet 1985, 8946: 100\u2013101.","journal-title":"Lancet"},{"key":"BF03343730_CR4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000184606","volume":"44","author":"C Carella","year":"1995","unstructured":"Carella C., Amato G., Biondi B., Rotondi M., Morisco F., Tuccillo C., Chiuchiolo N., Signoriello G., Caporaso N., Lombardi G. Longitudinal study of antibodies against thyroid in patients undergoing interferon-a therapy for HCV chronic hepatitis. Horm. Res. 1995, 44: 110\u2013114.","journal-title":"Horm. Res."},{"key":"BF03343730_CR5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0002-9343(96)00259-8","volume":"172","author":"E Roti","year":"1996","unstructured":"Roti E., Minelli R., Giuberti T., Marchelli S., Schianchi C., Gardini E., Salvi M., Fiaccadori F., Ugolotti G., Neri T.M., Braverman L.E. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. Am. J. Med. 1996, 172: 482\u2013487.","journal-title":"Am. J. Med."},{"key":"BF03343730_CR6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2265.1996.751768.x","volume":"44","author":"M Marazuela","year":"1996","unstructured":"Marazuela M., Garc\u00eda-Buey L., Gonz\u00e1lez-Fern\u00e1ndez B., Garc\u00eda-Monz\u00f3n C., Arranz A., Borque M.J., Moreno-Otero R. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-a therapy. Clin. Endocrinol. 1996, 44: 635\u2013642.","journal-title":"Clin. Endocrinol."},{"key":"BF03343730_CR7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-2007-1003651","volume":"23","author":"MC Pagliacci","year":"1991","unstructured":"Pagliacci M.C., Pelicci G., Schippa M., Liberati A.M., Nicoletti I. Does Interferon-\u03b2 therapy induce thyroid autoimmune phenomena? Horm. Metab. Res. 1991, 23: 196\u2013197.","journal-title":"Horm. Metab. Res."},{"key":"BF03343730_CR8","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1507\/endocrj.43.545","volume":"43","author":"Y Nagai","year":"1996","unstructured":"Nagai Y., Ohsawa K., Ieki Y., Kobayashi K. Effect of interferon-beta on thyroid function in patients of chronic hepatitis C without preexisting autoimmune thyroid disease. Endocr. J. 1996, 43: 545\u2013549.","journal-title":"Endocr. J."},{"key":"BF03343730_CR9","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/archneur.1997.00550210095020","volume":"54","author":"SR Schwid","year":"1997","unstructured":"Schwid S.R., Goodman A.D., Mattson D.H. Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta-1b. Arch. Neurol. 1997, 54: 1169\u20131170.","journal-title":"Arch. Neurol."},{"key":"BF03343730_CR10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF02427558","volume":"19","author":"V Martinelli","year":"1998","unstructured":"Martinelli V., Gironi M., Rodegher M., Martino G., Comi G. Occurence of thyroid autoimmunity in relapsing-remitting multiple sclerosis patients undergoing interferon-\u03b2 treatment. It. J. Neur. Sci. 1998, 19: 65\u201367.","journal-title":"It. J. Neur. Sci."},{"key":"BF03343730_CR11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/BF03348040","volume":"21","author":"M Rotondi","year":"1998","unstructured":"Rotondi M., Oliviero A., Profice P., Mone C.M., Biondi B., Del Buono A., Mazziotti G., Sinisi A.M., Bellastella A., Carella C. Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-\u03b2 therapy for multiple sclerosis. J. Endocrinol. Invest. 1998, 21: 748\u2013752.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03343730_CR12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-510X(98)00299-8","volume":"162","author":"L Durelli","year":"1999","unstructured":"Durelli L., Ferrero B., Oggero A., Verdun E., Bongioanni M.R., Gentile E., Isoardo G.L., Ricci A., Rota E., Bergamasco B., Durazzo M., Saracco G., Biava M.A., Brossa P.C., Giorda L., Pagni R., Aimo G. Autoimmune events during interferon beta-1b treatment for multiple sclerosis. J. Neurol. Sci. 1999, 162: 74\u201383.","journal-title":"J. Neurol. Sci."},{"key":"BF03343730_CR13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/eje.0.1410325","volume":"141","author":"F Monzani","year":"1999","unstructured":"Monzani F., Caraccio N., Meucci G., Lombardo F., Moscato G., Casolaro A., Ferdeghini M., Murri L., Ferrannini E. Effect of 1-year treatment with interferon-\u03b21b on thyroid function and autoimmunity in patients with multiple sclerosis. Eur. J. Endocrinol. 1999, 141: 325\u2013331.","journal-title":"Eur. J. Endocrinol."},{"key":"BF03343730_CR14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","volume":"13","author":"CM Poser","year":"1983","unstructured":"Poser C.M., Paty D.W., Scheinberg L., Mc Donald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.A., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 1983, 13: 227\u2013231.","journal-title":"Ann. Neurol."},{"key":"BF03343730_CR15","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33: 1444\u20131452.","journal-title":"Neurology"},{"key":"BF03343730_CR16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1600-0404.1998.tb05960.x","volume":"97","author":"P Kivisakk","year":"1998","unstructured":"Kivisakk P., Lundahl J., Von Heigl Z., Fredrikson S. No evidence for increased frequency of autoantibodies during interferon-\u03b21b treatment of multiple sclerosis. Acta Neurol. Scand. 1998, 97: 320\u2013323.","journal-title":"Acta Neurol. Scand."},{"key":"BF03343730_CR17","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.38.3.371","volume":"38","author":"J Keiser De","year":"1988","unstructured":"De Keiser J. Autoimmunity in multiple sclerosis. Neurology 1988, 38: 371\u2013374.","journal-title":"Neurology"},{"key":"BF03343730_CR18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(80)90575-9","volume":"1","author":"WR Kiessling","year":"1980","unstructured":"Kiessling W.R., Pflughaupt K.W. Antithyroid antibodies in multiple sclerosis. Lancet 1980, 1: 41.","journal-title":"Lancet"},{"key":"BF03343730_CR19","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/1097-0142(19900515)65:10<2237::AID-CNCR2820651013>3.0.CO;2-5","volume":"65","author":"K Conlon","year":"1990","unstructured":"Conlon K., Urba W., Smith J., Steis R., Longo D., Clark J. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 1990, 65: 2237\u20132242.","journal-title":"Cancer"},{"key":"BF03343730_CR20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0300-483X(95)03124-X","volume":"105","author":"T Vial","year":"1995","unstructured":"Vial T., Descotes J. Immune-mediated side-effects of cytokines in humans. Toxicology 1995, 105: 31\u201357.","journal-title":"Toxicology"},{"key":"BF03343730_CR21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2265.1993.tb02423.x","volume":"39","author":"E Baudin","year":"1993","unstructured":"Baudin E., Marcellin P., Pouteau M., Colas-Linhart N., Le Floch J.P., Lemmonier C., Benhamou J.P., Bok B. Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin. Endocrinol. 1993, 39: 657\u2013661.","journal-title":"Clin. Endocrinol."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03343730.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03343730\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03343730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T10:26:10Z","timestamp":1558520770000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03343730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["BF03343730"],"URL":"https:\/\/doi.org\/10.1007\/bf03343730","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}